Rodin Therapeutics had a suggestion from Golden's AI approved byOn June 27, 2013 Rodin Therapeutics closed their seed funding round with an undisclosed amount of funding from Johnson & Johnson Development Corporation and Atlas VentureAtlas Venture.
Revance Therapeutics had a suggestion from Golden's AI approved byRevance Therapeutics is a publicly held biotechnology company based in Newark, CaliforniaNewark, California. It specializes in developing neuromodulators for the treatment of asthetic and therapeutic conditions. Revance uses a proprietary stabilizing excipient peptide technology to create differentiated therapies.
Aclaris Therapeutics had a suggestion from Golden's AI approved byATI-502 is a topical JAK1/JAK3 inhibitor that is being investigated (Phase 2) for alopecia areataalopecia areata, including patchy alopecia areata and the more severe forms of the disease, alopecia totalis and alopecia universalis. The product is also under investigation (Phase 2) for androgenetic alopecia, vitiligo, and atopic dermatitis. In July 2017, Aclaris filed an IND (investigational new drug) application for ATI-502.
MaidSafeMaidsafe is an autonomous data network and blockchain based storage platform that is based in Ayr, Scotland, and was founded in 2006 by David IrvineDavid Irvine. MaidSafe offers its users the SAFE network which is a decentralized blockchain-based system and smart contract provider.
Revance Therapeutics had a suggestion from Golden's AI approved byThe skin that sits between the eyebrows and above the nose. Face wrinkling is promoted by habitual facial expressions, aging, sun damage, smoking, poor hydration, and various other factors. Late stage clinical studies have produced positive results, with RT002 poised to progress to commercialization. Revance has also entered into an agreement with Fosun Pharmaceuticals for the exclusive rights to develop and commercialize RT002 in Mainland China, Hong KongHong Kong, and Macau.